Clinical Trials Browser

INDUSTRY × Neurofibroma, Plexiform × Control Groups × Clear all

NCT05913037 2025-03-06

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Phase 3 Active not recruiting

Neurofibromatosis 1, Neurofibroma, Plexiform